Study Summary
This trial will test the effectiveness of the Minds and Mentors Program (MiMP) in treating individuals with opioid use disorder. The study will compare the MiMP to Twelve Step Facilitation, and will measure outcomes such as adherence to medication, rates of relapse and cravings, and self-reported anxiety, stress, and depression. Additionally, the trial will examine whether pre-intervention cortisol reactivity is predictive of relapse outcomes, and/ or whether reductions in cortisol reactivity over the course of intervention mediate relapse outcomes.
- Opioid Use Disorder
- Substance Use Disorder
- Medication Assisted Treatment
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 6 Secondary · Reporting Duration: 9 months
Trial Safety
Trial Design
2 Treatment Groups
12 Step Treatment Program
1 of 2
Mindfulness based relapse prevention and peer mentoring
1 of 2
Active Control
Experimental Treatment
240 Total Participants · 2 Treatment Groups
Primary Treatment: Minds and Mentors · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: